FDA lowers starting dose for sleeping aid Lunesta - New York News

FDA lowers starting dose for sleeping aid Lunesta

Posted: Updated:

By MATTHEW PERRONE AP Health Writer

WASHINGTON (AP) -- U.S. health officials are lowering the starting dose of the popular sleeping aid drug Lunesta, due to risks of morning drowsiness that can impair driving ability and lead to injury.

The Food and Drug Administration said Thursday it is taking action based on a study that found Lunesta users had problems with driving, memory and coordination up to 11 hours after first taking the drug. Patients are often unaware that they are still drowsy the morning after, according to the FDA, which monitors food and drugs for safety.

The results, published last month, compared 91 patients taking Lunesta or placebo while performing several tasks measuring coordination, memory and other cognitive measures.

Lunesta manufacturer Sunovion Pharmaceuticals, a subsidiary of Japanese drugmaker Dainippon Sumitomo Pharma, will lower the starting dose of the tablet to 1 milligram from currently available 2 milligrams. Patients can increase their dose to 2 or 3 milligrams, but should keep in mind that higher doses are more likely to cause next-day impairment, according to the FDA statement.

Patients currently taking 2 or 3 milligram doses of Lunesta should contact their doctor to get information about the most appropriate dose.

Drowsiness is a side effect listed on the labels of all anti-insomnia drugs, the agency release notes.

Thursday's announcement follows a similar FDA action last year that reduced the dosage of Ambien and other generic insomnia drugs containing the ingredient zolpidem. Those drugs are the most widely prescribed sleep aids in the U.S. Lunesta uses a different active ingredient called eszopiclone.

"Recently, data from clinical trials and other types of studies have become available, which allowed the FDA to better characterize the risk of next-morning impairment with sleep drugs," the FDA's Dr. Ellis Unger said in a statement.

Lunesta, launched in 2005, is designed to be taken before bed to help patients with insomnia fall asleep and stay asleep for up to 7 hours.

Calls to Sunovion Pharmaceuticals Inc. were not immediately returned Thursday afternoon.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • HealthMore>>

  • FDA Approves New Combination Rx for Type 2 Diabetes

    FDA Approves New Combination Rx for Type 2 Diabetes

    FDA Approves New Combination Rx for Type 2 Diabetes Invokamet combines Invokana and metformin to treat adults with Type 2 diabetes (dailyRx News) A healthy diet and regular exercise are the...
    FDA Approves New Combination Rx for Type 2 Diabetes Invokamet combines Invokana and metformin to treat adults with Type 2 diabetes (dailyRx News) A healthy diet and regular exercise are the mainstays of...
  • Why we yawn

    Why we yawn

    Tuesday, August 19 2014 10:53 PM EDT2014-08-20 02:53:59 GMT
    We all yawn, but why we do it has long been a mysterious phenomenon. Turns out scientists have disproved the old "getting oxygen to our brain" theory. While we often yawn when we're sleepy, it may not be the sleepiness that's causing the yawn. "It's not surprising that there's a heightened level of yawning associated with being sleepy," says Dr. Andrew Gallup, an assistant professor of psychology at SUNY Oneonta and a leading researcher on the subject of yawning.
    We all yawn, but why we do it has long been a mysterious phenomenon. Turns out scientists have disproved the old "getting oxygen to our brain" theory. While we often yawn when we're sleepy, it may not be the sleepiness that's causing the yawn. "It's not surprising that there's a heightened level of yawning associated with being sleepy," says Dr. Andrew Gallup, an assistant professor of psychology at SUNY Oneonta and a leading researcher on the subject of yawning.
  • Salmonella risk in peanut, almond butters

    Nut butter recall 2014

    Nut butter recall 2014

    Tuesday, August 19 2014 8:34 PM EDT2014-08-20 00:34:52 GMT
    Peanut and almond butters sold at Whole Foods, Trader Joe's and other grocers are being recalled because of possible salmonella contamination. A unit of Hain Celestial Group Inc. said Tuesday that there have been reports of four illnesses that may be related to the nut butters. They were sold under the brand names Arrowhead Mills Peanut Butters, MaraNatha Almond Butters and Peanut Butters, and private label brands for Whole Foods, Trader Joe's, Kroger and Safeway.
    Peanut and almond butters sold at Whole Foods, Trader Joe's and other grocers are being recalled because of possible salmonella contamination. A unit of Hain Celestial Group Inc. said Tuesday that there have been reports of four illnesses that may be related to the nut butters. They were sold under the brand names Arrowhead Mills Peanut Butters, MaraNatha Almond Butters and Peanut Butters, and private label brands for Whole Foods, Trader Joe's, Kroger and Safeway.
  • Local NewsLocal NewsMore>>

  • Times Square to go gold for cancer research

    Times Square to go gold for cancer research

    Wednesday, August 20 2014 8:40 AM EDT2014-08-20 12:40:36 GMT
    Things are looking up for cute little Cami King. Not only is her cancer in remission, she also just got to meet Mickey, Minnie and Elmo in Times Square. But, if you can believe it, there's something else this 4-year-old is even more excited about: Times Square is going gold. The chairman of the Times Square Advertising Coalition announced the crossroads of the world is going to light up in gold to raise awareness for pediatric cancer research.
    Things are looking up for cute little Cami King. Not only is her cancer in remission, she also just got to meet Mickey, Minnie and Elmo in Times Square. But, if you can believe it, there's something else this 4-year-old is even more excited about: Times Square is going gold. The chairman of the Times Square Advertising Coalition announced the crossroads of the world is going to light up in gold to raise awareness for pediatric cancer research.
  • Poll: Cuomo maintains big lead in NY gov race

    Poll: Cuomo maintains big lead in NY gov race

    Wednesday, August 20 2014 8:15 AM EDT2014-08-20 12:15:46 GMT
    Gov. Andrew CuomoGov. Andrew Cuomo
    A new poll shows Democratic Gov. Andrew Cuomo continues to maintain a 2-to-1 advantage over his Republican challenger in New York's gubernatorial race. The Quinnipiac University poll released Wednesday gives Cuomo a 56 to 28 percent lead over Westchester County Executive Rob Astorino. That's essentially unchanged from Quinnipiac's poll in May.
    A new poll shows Democratic Gov. Andrew Cuomo continues to maintain a 2-to-1 advantage over his Republican challenger in New York's gubernatorial race. The Quinnipiac University poll released Wednesday gives Cuomo a 56 to 28 percent lead over Westchester County Executive Rob Astorino. That's essentially unchanged from Quinnipiac's poll in May.
  • Tyga calls for Empire State Building to go gold

    Tyga calls for Empire State Building to go gold

    Wednesday, August 20 2014 8:12 AM EDT2014-08-20 12:12:32 GMT
    The push to go gold for pediatric cancer has spread to the hip hop world. Popular rapper Tyga is joining those calling for the Empire State Building to light up for a good cause.
    The push to go gold for pediatric cancer has spread to the hip hop world. Popular rapper Tyga is joining those calling for the Empire State Building to light up for a good cause.
Powered by WorldNow
Didn't find what you were looking for?
All content © Copyright 2000 - 2014 Fox Television Stations, Inc. and Worldnow. All Rights Reserved.
Privacy Policy | New Terms of Service What's new | Ad Choices